Financial toxicity in gynecologic oncology.

ABSTRACT:

Objectives

Financial toxicity is increasingly recognized as an adverse outcome of cancer treatment. Our objective was to measure financial toxicity among gynecologic oncology patients and its association with demographic and disease-related characteristics; self-reported overall health; and cost-coping strategies.

Methods

Follow-up patients at a gynecologic oncology practice completed a survey including the COmprehensive Score for Financial Toxicity (COST) tool and a self-reported overall health assessment, the EQ-VAS. We abstracted disease and treatment characteristics from medical records. We dichotomized COST scores into low and high financial toxicity and assessed the correlation (r) between COST scores and self-reported health. We calculated risk ratios (RR) and 95% con

SUBMITTER: Bouberhan S 

PROVIDER: S-EPMC7001853 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature